BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 30244386)

  • 21. Dual PET Imaging of an H3K27M-Mutant Glioma With 18F-GE-180 and 18F-FET PET.
    Vettermann FJ; Unterrainer M; Ruf V; Fleischmann DF; Rupprecht R; Forbrig R; Herms J; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL
    Clin Nucl Med; 2020 Dec; 45(12):992-993. PubMed ID: 33065624
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Suchorska B; Unterrainer M; Biczok A; Sosnova M; Forbrig R; Bartenstein P; Tonn JC; Albert NL; Kreth FW
    J Neurooncol; 2018 Sep; 139(3):721-730. PubMed ID: 29948765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Static and dynamic
    Verger A; Stoffels G; Bauer EK; Lohmann P; Blau T; Fink GR; Neumaier B; Shah NJ; Langen KJ; Galldiks N
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):443-451. PubMed ID: 29043400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiotherapy target volume definition in newly diagnosed high grade glioma using
    Dissaux G; Dissaux B; Kabbaj OE; Gujral DM; Pradier O; Salaün PY; Seizeur R; Bourhis D; Ben Salem D; Querellou S; Schick U
    Radiother Oncol; 2020 Sep; 150():164-171. PubMed ID: 32580001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of 3'-deoxy-3'-[18F]fluorothymidine PET and O-(2-[18F]fluoroethyl)-L-tyrosine PET in patients with newly diagnosed glioma.
    Jeong SY; Lim SM
    Nucl Med Biol; 2012 Oct; 39(7):977-81. PubMed ID: 22483845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma.
    Rapp M; Heinzel A; Galldiks N; Stoffels G; Felsberg J; Ewelt C; Sabel M; Steiger HJ; Reifenberger G; Beez T; Coenen HH; Floeth FW; Langen KJ
    J Nucl Med; 2013 Feb; 54(2):229-35. PubMed ID: 23232275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intra-lesional spatial correlation of static and dynamic FET-PET parameters with MRI-based cerebral blood volume in patients with untreated glioma.
    Göttler J; Lukas M; Kluge A; Kaczmarz S; Gempt J; Ringel F; Mustafa M; Meyer B; Zimmer C; Schwaiger M; Förster S; Preibisch C; Pyka T
    Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):392-397. PubMed ID: 27913827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
    Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of O-(2-
    Verger A; Filss CP; Lohmann P; Stoffels G; Sabel M; Wittsack HJ; Kops ER; Galldiks N; Fink GR; Shah NJ; Langen KJ
    World Neurosurg; 2018 May; 113():e727-e737. PubMed ID: 29510293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.
    Verburg N; Koopman T; Yaqub MM; Hoekstra OS; Lammertsma AA; Barkhof F; Pouwels PJW; Reijneveld JC; Heimans JJ; Rozemuller AJM; Bruynzeel AME; Lagerwaard F; Vandertop WP; Boellaard R; Wesseling P; de Witt Hamer PC
    Neuro Oncol; 2020 Mar; 22(3):412-422. PubMed ID: 31550353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation.
    Fleischmann DF; Unterrainer M; Corradini S; Rottler M; Förster S; la Fougère C; Siepmann T; Schwaiger M; Bartenstein P; Belka C; Albert NL; Niyazi M
    PLoS One; 2019; 14(7):e0216111. PubMed ID: 31339892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors.
    Filss CP; Galldiks N; Stoffels G; Sabel M; Wittsack HJ; Turowski B; Antoch G; Zhang K; Fink GR; Coenen HH; Shah NJ; Herzog H; Langen KJ
    J Nucl Med; 2014 Apr; 55(4):540-5. PubMed ID: 24578243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic 18F-FET PET is a powerful imaging biomarker in gadolinium-negative gliomas.
    Kunz M; Albert NL; Unterrainer M; la Fougere C; Egensperger R; Schüller U; Lutz J; Kreth S; Tonn JC; Kreth FW; Thon N
    Neuro Oncol; 2019 Feb; 21(2):274-284. PubMed ID: 29893965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatial Relationship of Glioma Volume Derived from
    Mauler J; Maudsley AA; Langen KJ; Nikoubashman O; Stoffels G; Sheriff S; Lohmann P; Filss C; Galldiks N; Kops ER; Shah NJ
    J Nucl Med; 2018 Apr; 59(4):603-609. PubMed ID: 28848036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?
    Jansen NL; Graute V; Armbruster L; Suchorska B; Lutz J; Eigenbrod S; Cumming P; Bartenstein P; Tonn JC; Kreth FW; la Fougère C
    Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):1021-9. PubMed ID: 22491781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An intra-individual comparison of MRI, [18F]-FET and [18F]-FLT PET in patients with high-grade gliomas.
    Nowosielski M; DiFranco MD; Putzer D; Seiz M; Recheis W; Jacobs AH; Stockhammer G; Hutterer M
    PLoS One; 2014; 9(4):e95830. PubMed ID: 24759867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of
    Debus C; Waltenberger M; Floca R; Afshar-Oromieh A; Bougatf N; Adeberg S; Heiland S; Bendszus M; Wick W; Rieken S; Haberkorn U; Debus J; Knoll M; Abdollahi A
    Sci Rep; 2018 May; 8(1):7201. PubMed ID: 29740097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of 18F-FET PET/CT in newly diagnosed WHO 2016 high-grade glioma.
    Dissaux G; Basse V; Schick U; El Kabbaj O; Auberger B; Magro E; Kassoul A; Abgral R; Salaun PY; Bourhis D; Querellou S
    Medicine (Baltimore); 2020 Jan; 99(5):e19017. PubMed ID: 32000446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas.
    Floeth FW; Sabel M; Ewelt C; Stummer W; Felsberg J; Reifenberger G; Steiger HJ; Stoffels G; Coenen HH; Langen KJ
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):731-41. PubMed ID: 21153408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
    Lapa C; Linsenmann T; Monoranu CM; Samnick S; Buck AK; Bluemel C; Czernin J; Kessler AF; Homola GA; Ernestus RI; Löhr M; Herrmann K
    J Nucl Med; 2014 Oct; 55(10):1611-6. PubMed ID: 25125481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.